CLINICAL_TRIALS
trial_result
· 2010-02-02
Clinical Trial Update: Long-term Extension From RCC Phase II (11515) [Phase 2]
Summary
Long-term extension of a Phase II renal cell carcinoma trial completed. Results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2010-02-02